-
1
-
-
0034843738
-
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
-
GOFF, D. & J.T. COYLE. 2001. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158(9): 1367-1377.
-
(2001)
Am. J. Psychiatry
, vol.158
, Issue.9
, pp. 1367-1377
-
-
Goff, D.1
Coyle, J.T.2
-
2
-
-
0037308528
-
Genes for schizophrenia? Recent findings and their pathophysiological implications
-
HARRISON, P.J. & M.J. OWEN. 2003. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361(9355): 417-419.
-
(2003)
Lancet
, vol.361
, Issue.9355
, pp. 417-419
-
-
Harrison, P.J.1
Owen, M.J.2
-
3
-
-
0033956237
-
Schizophrenia: Genes and environment
-
TSUANG, M. 2000. Schizophrenia: genes and environment. Biol. Psychiatry 47(3): 210-220.
-
(2000)
Biol. Psychiatry
, vol.47
, Issue.3
, pp. 210-220
-
-
Tsuang, M.1
-
4
-
-
0019462450
-
Dopamine receptors, neuroleptics, and schizophrenia
-
SNYDER, S.H. 1981. Dopamine receptors, neuroleptics, and schizophrenia. Am. J. Psychiatry 138(4): 460-464.
-
(1981)
Am. J. Psychiatry
, vol.138
, Issue.4
, pp. 460-464
-
-
Snyder, S.H.1
-
5
-
-
0031417026
-
Treatment-resistant schizophrenia - The role of clozapine
-
MELTZER, H.Y. 1997. Treatment-resistant schizophrenia - the role of clozapine. Curr Med. Res. Opin. 14(1): 1-20.
-
(1997)
Curr. Med. Res. Opin.
, vol.14
, Issue.1
, pp. 1-20
-
-
Meltzer, H.Y.1
-
6
-
-
0014078609
-
Effect of phencyclidine in chronic schizophrenics
-
ITIL, T. et al. 1967. Effect of phencyclidine in chronic schizophrenics. Can. Psychiatr. Assoc. J. 12(2): 209-212.
-
(1967)
Can. Psychiatr. Assoc. J.
, vol.12
, Issue.2
, pp. 209-212
-
-
Itil, T.1
-
7
-
-
70449240781
-
Study of a new schizophrenomimetic drug - Sernyl
-
LUBY, E.D. et al. 1959. Study of a new schizophrenomimetic drug - sernyl. Arch. Neurol. Psychiatry 81: 363-369.
-
(1959)
Arch. Neurol. Psychiatry
, vol.81
, pp. 363-369
-
-
Luby, E.D.1
-
8
-
-
0025952455
-
Recent advances in the phencyclidine model of schizophrenia
-
JAVITT, D.C. & S.R. ZUKIN. 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148(10): 1301-1308.
-
(1991)
Am. J. Psychiatry
, vol.148
, Issue.10
, pp. 1301-1308
-
-
Javitt, D.C.1
Zukin, S.R.2
-
9
-
-
0028323167
-
Subanaesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
-
KRYSTAL, J.H. et al. 1994. Subanaesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51(3): 199-214.
-
(1994)
Arch. Gen. Psychiatry
, vol.51
, Issue.3
, pp. 199-214
-
-
Krystal, J.H.1
-
10
-
-
0030749913
-
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
-
MALHOTRA, A.K. et al. 1997. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17(3): 141-150.
-
(1997)
Neuropsychopharmacology
, vol.17
, Issue.3
, pp. 141-150
-
-
Malhotra, A.K.1
-
11
-
-
0033080733
-
Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis
-
NEWCOMER, J. et al. 1999. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20(2): 106-118.
-
(1999)
Neuropsychopharmacology
, vol.20
, Issue.2
, pp. 106-118
-
-
Newcomer, J.1
-
12
-
-
0036501435
-
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
-
UMBRICHT, D. et al. 2002. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol. Psychiatry 51(5): 400-406.
-
(2002)
Biol. Psychiatry
, vol.51
, Issue.5
, pp. 400-406
-
-
Umbricht, D.1
-
13
-
-
0036711792
-
Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia
-
AVILA, M.T. et al. 2002. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. Am. J. Psychiatry 159(9): 1490-1496.
-
(2002)
Am. J. Psychiatry
, vol.159
, Issue.9
, pp. 1490-1496
-
-
Avila, M.T.1
-
15
-
-
0030900732
-
Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
-
MOGHADDAM, B. et al. 1997. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17(8): 2921-2927.
-
(1997)
J. Neurosci.
, vol.17
, Issue.8
, pp. 2921-2927
-
-
Moghaddam, B.1
-
16
-
-
0034307054
-
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
-
KEGELES, L.S. et al. 2000. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Proc. Natl. Acad. Sci. USA 48(7): 627-640.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.48
, Issue.7
, pp. 627-640
-
-
Kegeles, L.S.1
-
17
-
-
0034106451
-
Linking Hebb's coincidence-detection to memory formation
-
TSIEN, J.Z. 2000. Linking Hebb's coincidence-detection to memory formation. Curr. Opin. Neurobiol. 10(2): 266-273.
-
(2000)
Curr. Opin. Neurobiol.
, vol.10
, Issue.2
, pp. 266-273
-
-
Tsien, J.Z.1
-
18
-
-
0034712857
-
D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor
-
MOTHET, J.-P. et al. 2000. D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA 97(9): 4926-4931.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, Issue.9
, pp. 4926-4931
-
-
Mothet, J.-P.1
-
19
-
-
0028348479
-
Cloning of the human glycine transporter type 1: Molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes
-
KIM, K.M. et al. 1994. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Mol. Pharmacol. 45(4): 608-617.
-
(1994)
Mol. Pharmacol.
, vol.45
, Issue.4
, pp. 608-617
-
-
Kim, K.M.1
-
20
-
-
0032441894
-
Modulation of N-methyl-D-aspartate receptor function by glycine transport
-
BERGERON, R. et al. 1998. Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc. Natl. Acad. Sci. USA 95(26): 15730-15734.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, Issue.26
, pp. 15730-15734
-
-
Bergeron, R.1
-
21
-
-
0032415129
-
Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses
-
BERGER, A.J. et al. 1998. Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J. Neurophysiol. 80(6): 3336-3340.
-
(1998)
J. Neurophysiol.
, vol.80
, Issue.6
, pp. 3336-3340
-
-
Berger, A.J.1
-
22
-
-
0037320805
-
Glycine transporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo
-
CHEN, L. et al. 2003. Glycine transporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. J. Neurophysiol. 89(2): 691-703.
-
(2003)
J. Neurophysiol.
, vol.89
, Issue.2
, pp. 691-703
-
-
Chen, L.1
-
23
-
-
0035477818
-
Increased cortical kynurenate content in schizophrenia
-
SCHWARCZ, R. et al. 2001. Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50(7): 521-530.
-
(2001)
Biol. Psychiatry
, vol.50
, Issue.7
, pp. 521-530
-
-
Schwarcz, R.1
-
24
-
-
0033530857
-
Glutamate carboxypeptidase II is expressed by astrocytes in the rat nervous system
-
BERGER, U.V. et al. 1999. Glutamate carboxypeptidase II is expressed by astrocytes in the rat nervous system. J. Comp. Neurol. 415: 52-64.
-
(1999)
J. Comp. Neurol.
, vol.415
, pp. 52-64
-
-
Berger, U.V.1
-
25
-
-
0028875197
-
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains
-
TSAI, G. et al. 1995. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry 52(10): 829-836.
-
(1995)
Arch. Gen. Psychiatry
, vol.52
, Issue.10
, pp. 829-836
-
-
Tsai, G.1
-
26
-
-
0035836642
-
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
-
HAKAK, Y. et al. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98(8): 4746-4751.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, Issue.8
, pp. 4746-4751
-
-
Hakak, Y.1
-
27
-
-
0035098294
-
Beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor
-
LEA, P.M. IV et al. 2001 beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor. J. Neurophysiol. 85(3): 1097-1106.
-
(2001)
J. Neurophysiol.
, vol.85
, Issue.3
, pp. 1097-1106
-
-
Lea IV, P.M.1
-
28
-
-
38149138747
-
Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population
-
MARTI, S.B. et al. 2002. Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. Am. J. Med. Genet. 114(1): 46-50.
-
(2002)
Am. J. Med. Genet.
, vol.114
, Issue.1
, pp. 46-50
-
-
Marti, S.B.1
-
29
-
-
0037108758
-
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia
-
CHUMAKOV, I. et al. 2002 Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. USA 99(21): 13675-13680.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, Issue.21
, pp. 13675-13680
-
-
Chumakov, I.1
-
30
-
-
0037977113
-
Decreased serum levels of D-serine in patients with schizophrenia: Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
-
HASHIMOTO, K. et al. 2003. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 60(6): 572-576.
-
(2003)
Arch. Gen. Psychiatry
, vol.60
, Issue.6
, pp. 572-576
-
-
Hashimoto, K.1
-
31
-
-
0035368610
-
Receptor signaling pathways in the nervous system
-
BUONANNO, A. et al. 2001 Receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11(3): 287-296.
-
(2001)
Curr. Opin. Neurobiol.
, vol.11
, Issue.3
, pp. 287-296
-
-
Buonanno, A.1
-
32
-
-
0013375948
-
Neuregulin 1 and susceptibility to schizophrenia
-
STEFANSSON, H. et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71(4): 877-892.
-
(2002)
Am. J. Hum. Genet.
, vol.71
, Issue.4
, pp. 877-892
-
-
Stefansson, H.1
-
33
-
-
0030044715
-
The glutamatergic dysfunction hypothesis for schizophrenia
-
COYLE, J.T. 1996. The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev. Psychiatry 3(5): 241-253.
-
(1996)
Harvard Rev. Psychiatry
, vol.3
, Issue.5
, pp. 241-253
-
-
Coyle, J.T.1
-
34
-
-
0029880412
-
NMDA-dependent modulation of CA1 local circuit inhibition
-
GRUNZE, H.C. et al. 1996. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16(6): 2034-2043.
-
(1996)
J. Neurosci.
, vol.16
, Issue.6
, pp. 2034-2043
-
-
Grunze, H.C.1
-
35
-
-
0029646097
-
Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?
-
FARBER, N.B. et al. 1995. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol. Psychiatry 15: 788-796.
-
(1995)
Biol. Psychiatry
, vol.15
, pp. 788-796
-
-
Farber, N.B.1
-
36
-
-
0037092430
-
NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: A potential mechanism of neurotoxicity
-
LI, Q. et al. 2002. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J. Neurosci. 22: 3070-3080.
-
(2002)
J. Neurosci.
, vol.22
, pp. 3070-3080
-
-
Li, Q.1
-
37
-
-
0033759439
-
Decrease in reelin and glutamic acid decarboxylase67 (GAD 67) expression in schizophrenia and bipolar disorder: A postmortem study
-
GUIDOTTI, A. et al. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD 67) expression in schizophrenia and bipolar disorder: A postmortem study. Arch. Gen Psychiatry 57(11): 1061-1069.
-
(2000)
Arch. Gen Psychiatry
, vol.57
, Issue.11
, pp. 1061-1069
-
-
Guidotti, A.1
-
38
-
-
0034011252
-
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia
-
VOLK, D. et al. 2000. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen Psychiatry 57: 237-245.
-
(2000)
Arch. Gen Psychiatry
, vol.57
, pp. 237-245
-
-
Volk, D.1
-
39
-
-
0035140656
-
GABa transporter-1 mRNA in prefrontal cortex in schizophrenia: Decreased expression in a subset of neurons
-
VOLK, D. et al. 2001. GABA transporter-1 mRNA in prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am. J. Psychiatry 158(2): 256-265.
-
(2001)
Am. J. Psychiatry
, vol.158
, Issue.2
, pp. 256-265
-
-
Volk, D.1
-
40
-
-
0036784474
-
Reciprocal alterations in pre- and post-synaptic inhibitory markers at chandler cell inputs to pyramidal neurons in schizophrenia
-
VOLK, D.W. et al. 2002. Reciprocal alterations in pre-and post-synaptic inhibitory markers at chandler cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex 12(10): 1063-1070.
-
(2002)
Cereb. Cortex
, vol.12
, Issue.10
, pp. 1063-1070
-
-
Volk, D.W.1
-
41
-
-
0030331175
-
Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects
-
BENES, F.M. et al. 1996. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75(4): 1021-1031.
-
(1996)
Neuroscience
, vol.75
, Issue.4
, pp. 1021-1031
-
-
Benes, F.M.1
-
42
-
-
0037441519
-
Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats
-
PAULSON, L. et al. 2003. Comparative genome-and proteome analysis of cerebral cortex from MK-801-treated rats. J. Neurosci. Res. 71(4): 526-533.
-
(2003)
J. Neurosci. Res.
, vol.71
, Issue.4
, pp. 526-533
-
-
Paulson, L.1
-
43
-
-
0037942706
-
Ionotropic glutamate receptors as therapeutic targets in schizophrenia
-
COYLE, J.T. et al. 2002. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr. Drug Targets CNS Neurol. Disorders 1: 183-189.
-
(2002)
Curr. Drug Targets CNS Neurol. Disorders
, vol.1
, pp. 183-189
-
-
Coyle, J.T.1
-
44
-
-
0033558578
-
AE Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
-
JAVITT, D.C. et al. 1999. AE Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. Biol. Psychiatry 45(6): 668-679.
-
(1999)
Biol. Psychiatry
, vol.45
, Issue.6
, pp. 668-679
-
-
Javitt, D.C.1
-
45
-
-
0032925438
-
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
-
HERESCO-LEVY, U. et al. 1999. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch. Gen. Psychiatry 56(1): 29-36.
-
(1999)
Arch. Gen. Psychiatry
, vol.56
, Issue.1
, pp. 29-36
-
-
Heresco-Levy, U.1
-
46
-
-
0032403626
-
D-Serine added to antipsychotics for the treatment of schizophrenia
-
TSAI, G. et al. 1998. D-Serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry 44(11): 1081-1089.
-
(1998)
Biol. Psychiatry
, vol.44
, Issue.11
, pp. 1081-1089
-
-
Tsai, G.1
-
47
-
-
0034898096
-
Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine
-
SHEININ, A. et al. 2001. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine. Neuropharmacology 41(2): 151-158.
-
(2001)
Neuropharmacology
, vol.41
, Issue.2
, pp. 151-158
-
-
Sheinin, A.1
-
48
-
-
0037008687
-
Direct calcium binding results in activation of brain serine racemase
-
COOK, S.P. et al. 2002. Direct calcium binding results in activation of brain serine racemase. J. Biol. Chem. 277: 27782-27792.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 27782-27792
-
-
Cook, S.P.1
-
49
-
-
0029116094
-
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
-
GOFF, D.C, et al. 1995. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am. J. Psychiatry 152(8): 1213-1215.
-
(1995)
Am. J. Psychiatry
, vol.152
, Issue.8
, pp. 1213-1215
-
-
Goff, D.C.1
-
50
-
-
0032902238
-
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
-
GOFF, D.C. et al. 1999. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch. Gen. Psychiatry 56(1): 21-27.
-
(1999)
Arch. Gen. Psychiatry
, vol.56
, Issue.1
, pp. 21-27
-
-
Goff, D.C.1
-
51
-
-
0036184549
-
Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia
-
HORESCO-LEVY, U. et al. 2002. Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. Am. J. Psychiatry 159: 480-482.
-
(2002)
Am. J. Psychiatry
, vol.159
, pp. 480-482
-
-
Horesco-Levy, U.1
-
52
-
-
0345899818
-
Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for treatment of schizophrenia
-
In press
-
TSAI, G. et al. 2003. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for treatment of schizophrenia. Biol. Psychiatry. In press.
-
(2003)
Biol. Psychiatry.
-
-
Tsai, G.1
-
53
-
-
0041653565
-
Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: A longitudinal magnetic resonance imaging study
-
KASAI, K. et al. 2003. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 60(8): 766-775.
-
(2003)
Arch. Gen. Psychiatry
, vol.60
, Issue.8
, pp. 766-775
-
-
Kasai, K.1
|